Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Non Operating Income (2019 - 2025)

Korro Bio's Other Non Operating Income history spans 7 years, with the latest figure at $990000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 49.07% year-over-year to $990000.0, compared with a TTM value of $5.2 million through Dec 2025, down 38.23%, and an annual FY2025 reading of $5.2 million, down 38.23% over the prior year.
  • Other Non Operating Income for Q4 2025 was $990000.0 at Korro Bio, down from $1.2 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $2.3 million in Q2 2024, with the low at -$227000.0 in Q2 2022.
  • Average Other Non Operating Income over 5 years is $951789.5, with a median of $786000.0 recorded in 2023.
  • Biggest YoY gain for Other Non Operating Income was 15525.0% in 2022; the steepest drop was 22600.0% in 2022.
  • Tracing KRRO's Other Non Operating Income over 5 years: stood at -$4000.0 in 2021, then skyrocketed by 15575.0% to $619000.0 in 2022, then surged by 137.0% to $1.5 million in 2023, then skyrocketed by 32.52% to $1.9 million in 2024, then crashed by 49.07% to $990000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Other Non Operating Income are $990000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025).